MabVax Therapeutics: Novel Anti-Cancer Immunotherapies Based on Human Antibodies

Jun. 5, 2017
MabVax Therapeutics Holdings, Inc. (NASDAQ: MBVX) is a clinical-stage biotechnology company with a fully-human antibody discovery platform focused on the ...

 Read More

"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President, NASDAQ Stock Market